Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
Neurophysiologie Clinique = Clinical Neurophysiology|December 20, 2002
[Comparison of spectral analysis and non-linear analysis of EEG in patients with cognitive decline]Ph Gallois, G Forzy, J J Leduc, et al.Sensors (Basel, Switzerland)|February 15, 2022
Oligoclonal Band Straightening Based on Optimized Hierarchical Warping for Multiple Sclerosis DiagnosisFarah Haddad, Samuel Boudet, Laurent Peyrodie, et al.Multiple Sclerosis and Related Disorders|January 27, 2020
Socioeconomic deprivation increases the risk of disability in multiple sclerosis patientsFloriane Calocer, Olivier Dejardin, Arnaud Kwiatkowski, et al.Gastroenterologie Clinique Et Biologique|January 1, 1996
[Prevalence of serum anti-hepatitis C virus antibodies and risk factors of contamination in the personnel of a hospital in the Paris region. A prospective survey]M F Maillard, T Poynard, P Dubreuil, et al.Acta Neurologica Scandinavica|February 13, 2003
Multiple sclerosis, interferon beta and clinical thyroid dysfunctionA Kreisler, J de Seze, T Stojkovic, et al.Revue Neurologique|January 1, 1993
[Unconjugated pteridines and neuromeningeal infections]P Chatelet, P Hautecoeur, J L Dhondt, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 2007
[Variations of radiation dosage delivered to patients undergoing interventional cardiological procedures. A monocentric study 2002-05]J L Georges, B Livarek, G Gibault-Genty, et al.Journal of the Neurological Sciences|February 5, 2004
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patientsH Zephir, J de Seze, A Duhamel, et al.Revue Neurologique|April 9, 2002
[Treatment of progressive multiple sclerosis with cyclophosphamide]H Zephir, J De Seze, O Sénéchal, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2019
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)William Camu, Philippe Lehert, Charles Pierrot-Deseilligny, et al.Pageof 8